SGTXSigilon Therapeutics, Inc.

Nasdaq sigilon.com


$ 22.38 $ -0.59 (-2.56 %)    

Thursday, 10-Aug-2023 15:40:51 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 22.47
$ 22.54
$ 22.50 x 200
$ 27.01 x 100
$ 22.25 - $ 22.54
$ 3.77 - $ 28.00
83,681
na
56.22M
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2023 06-30-2023 10-Q
2 05-09-2023 03-31-2023 10-Q
3 03-14-2023 12-31-2022 10-K
4 11-10-2022 09-30-2022 10-Q
5 08-04-2022 06-30-2022 10-Q
6 05-12-2022 03-31-2022 10-Q
7 03-14-2022 12-31-2021 10-K
8 11-10-2021 09-30-2021 10-Q
9 08-10-2021 06-30-2021 10-Q
10 05-10-2021 03-31-2021 10-Q
11 03-18-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 over-25m-bet-on-this-healthcare-stock-check-out-these-3-stocks-insiders-are-buying

Although U.S. stocks closed mostly higher on Monday, there were a few notable insider trades.

 canaccord-genuity-maintains-buy-on-sigilon-therapeutics-raises-price-target-to-30

Canaccord Genuity analyst Whitney Ijem maintains Sigilon Therapeutics (NASDAQ:SGTX) with a Buy and raises the price target f...

 morgan-stanley-maintains-equal-weight-on-sigilon-therapeutics-raises-price-target-to-21

Morgan Stanley analyst Matthew Harrison maintains Sigilon Therapeutics (NASDAQ:SGTX) with a Equal-Weight and raises the pric...

 morgan-stanley-maintains-equal-weight-on-sigilon-therapeutics-raises-price-target-to-21

Morgan Stanley analyst Matthew Harrison maintains Sigilon Therapeutics (NASDAQ:SGTX) with a Equal-Weight and raises the pric...

 btig-downgrades-sigilon-therapeutics-to-neutral

BTIG analyst Thomas Shrader downgrades Sigilon Therapeutics (NASDAQ:SGTX) from Buy to Neutral.

 nasdaq-moves-lower-acuity-brands-earnings-top-estimates

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow trad...

 why-franklin-covey-shares-are-trading-higher-by-25-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the com...

 crude-oil-edges-higher-mccormick-posts-upbeat-earnings

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow traded ...

 dow-rises-over-100-points-us-gdp-grows-2-in-q1

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Thursday. Following the market open...

 sigilon-therapeutics-shares-are-shooting-higher-today---whats-going-on

Sigilon Therapeutics Inc (NASDAQ: SGTX) shares are skyrocketing after Eli Lilly And Co (NYSE: LLY) agreed to acquire the compan...

Core News & Articles

Lilly will commence a tender offer to acquire all outstanding shares of Sigilon for a purchase price of $14.92 per share in cas...

 morgan-stanley-maintains-equal-weight-on-sigilon-therapeutics-lowers-price-target-to-7

Morgan Stanley analyst Matthew Harrison maintains Sigilon Therapeutics (NASDAQ:SGTX) with a Equal-Weight and lowers the pric...

 morgan-stanley-maintains-equal-weight-on-sigilon-therapeutics-raises-price-target-to-91

Morgan Stanley analyst Matthew Harrison maintains Sigilon Therapeutics (NASDAQ:SGTX) with a Equal-Weight and raises the pric...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION